Polymerase Chain Reaction Market: Overview
The polymerase chain reaction market size was USD 31.5 billion in 2021, and it is expected to expand at 8.5 percent CAGR during the forecast period. Polymerase chain reaction (PCR) is a technique to duplicate a specific section of DNA. PCR is often used to generate multiple copies of the desired target DNA for subsequent analysis. DNA nucleotides, DNA templates, primers, Taq polymerase, and buffer are the five main materials used in a polymerase chain reaction. PCR is widely recognized as a more efficient and convenient technology.
The growing geriatric population drives the polymerase chain reaction market, the number of hospitals, technical improvements, and the increased frequency of infectious diseases. Polymerase chain reaction technologies are being driven by technology improvements, consumer acceptance of personalized medicine, and increased awareness of advanced procedures, accelerating the polymerase chain reaction market growth. The COVID-19 epidemic has caused the sector to grow exponentially in 2020 and 2021. The introduction of technologically advanced PCR tests into the Market has increased due to the development of novel rt-PCR tests for detecting SARS-CoV-2 infection and increased research and development activities to investigate the disease. For example, in June 2021, F. Hoffmann-La Roche Ltd. announced that the US FoodU.S.and Drug Administration had approved the Cobas SARS-CoV-2 nucleic acid test to detect asymptomatic and symptomatic people in point-of-care settings. Similarly, a large number of businesses have acquired global approval for innovative PCR assays for the identification of SARS-CoV-2 infection. However, declining demand for COVID-19 disorders is expected to stifle growth in the next years.
The rising number of infectious diseases and chronic and genetic disorders is likely to drive up demand during the forecast period. According to the CDC, chronic diseases such as cancer and diabetes and chronic renal and respiratory disorders such as asthma account for 7 out of every 10 fatalities in the United States annually. Furthermore, the number of people suffering from the congenital cardiac disease is increasing, necessitating the search for molecular diagnostic techniques to make reliable diagnoses.
Polymerase Chain Reaction Market: COVID-19 Impact
COVID-19 can impact the economy in three ways: disrupting distribution networks, directly impacting medication supply and demand, and having a financial impact on enterprises and financial markets. Several countries, including China, India, Egypt, the United Arab Emirates, Saudi Arabia, and others, are experiencing difficulties moving pharmaceuticals from one location to another due to nationwide lockdowns. However, the COVID-19 pandemic had a favorable impact on the worldwide polymerase chain reaction market due to the use of the polymerase chain reaction technique in covid-19 detection. For example, according to PubMed data from January 2020, zoonotic transmission of the SARS coronavirus from animals to people was found using traditional Reverse Transcription-Polymerase Chain Reaction (RT-PCR) techniques that target a highly conserved sequence among coronaviruses. Initially, reverse transcription polymerase chain reaction (RT-PCR) assays were employed to identify coronaviruses in bats.
Polymerase Chain Reaction Market: Drivers
Increasing Number of Patients for Chronic and Infectious Diseases is Growing Market
A polymerase chain reaction is rapidly employed in clinical infectious illness diagnosis, nucleic acid amplification, paternity testing, DNA fingerprinting, infectious disease detection and diagnosis, quality control, and customized medicine. For example, according to Indian Council of Medical Research in March 2022, there will be a 12% increase in cancer incidence in India by 2027. Breast cancer, cervical cancer, and oral cancer are the most frequent types of cancer in India. Furthermore, according to data published by the National Center for Biotechnology Information in May 2022, the estimated cancer burden in India for 2021 was 26.7 million, projected to be 29.8 million in 2025.
Advances Techniques to Accelerate Market Growth
Polymerase chain reaction (PCR) is an enzyme-driven in vitro procedure for amplifying a small section of DNA. Despite this amplification capability, the technology's accompanying gear constraints prevent it from attaining its full potential. Technological improvements and increased demand for novel products have resulted in the shrinking of devices on the Market. These tiny gadgets provide patients and healthcare practitioners with various clinical benefits. The launch of novel gadgets by leading market participants is expected to drive the global Market over the forecast period. For example, Bio-Rad Laboratories, Inc. announced the release of the QX ONE Droplet Digital PCR System in November 2019, which is intended for drug development, manufacturing quality control, and other highly critical testing conditions.
Polymerase Chain Reaction Market: Restraints
High Assay Costs, Combined With Lack Of Awareness in Developing Countries, are Stifling Market Growth
Despite the rising prevalence of infectious diseases worldwide, various limitations limit diagnostic instrument adoption. One of the primary problems impeding this Market's growth is a lack of awareness about the technology sector in low-income countries. Furthermore, the high cost of tests performed in developing countries is anticipated to reduce device adoption, limiting the market growth. According to the Skytrax 2021 report, a test in Kansai, Japan, costs roughly USD 404, whereas a test in New York, USA, costs around USD 179. As a result, higher assay costs are expected to reduce test uptake during the forecast period.
Polymerase Chain Reaction Market: Segment Overview
Conventional PCR to Dominate Market due to Increased Used in Food Testing And Safety
The increased use of traditional PCR in food testing and safety and an increase in new introductions are driving growth. Continuous growth in the number of diagnostic tests and the introduction of new reagents relevant to the test type are expected to boost demand for polymerase chain reaction reagents. Furthermore, high demand for testing supplies for the SARS-CoV-2 pandemic and increased availability of technologically advanced diagnostic equipment in nations with unmet clinical needs will drive PCR market sales. In addition, introducing new items is projected to help the segment's growth. For example, LGC Limited announced the launch of its end-point PCR test in April 2021 after receiving Emergency Use Authorization (EUA) from the U.S. FDU.S.his system is one of the best-performing on the Market due to its large testing capacity of 35,000 tests per day.
High Adoption Rate Of PCR Tests, Medical Category Dominated Market
Due to the high adoption rate of PCR tests for clinical diagnostics and research operations to study diseases and medication development, the medical segment represented the greatest revenue share. Furthermore, the expanding use of PCR in identifying SARS-CoV-2 infections, as well as medication development and research activities, is driving up demand for testing. Furthermore, the rising commercialization of qPCR and dPCR reagents for diagnostics and increasing applications for illness diagnosis, monitoring, and treatment are driving market expansion. According to an August 2020 article, PCR past, present, and future are two major areas of PCR utilization in bioscience: high-throughput PCR systems and microfluidics-based PCR devices for point-of-care (POC) applications.
Furthermore, the increasing COVID-19 instances and illness transmission in major countries have increased the demand for virus diagnostic testing in the suspected population. This tendency primarily results from a lack of speedy or specific diagnostic diagnostics for such disorders.
Polymerase Chain Reaction Market: Regional Landscape
North America to Dominate Market due to Increasing Prevalence of Genetic And Chronic Disorders
The North American Market is expected to account for the biggest revenue share throughout the forecast period. Within North America, the United States has dominated the Market. Many market players engaged in manufacturing, the increasing prevalence of genetic and chronic disorders such as cancer, the aging population, the rising demand for precision and personalized medicine, and favorable government initiatives are the major dynamics contributing to market growth.
For example, because COVID-19 cases are increasing rapidly and the virus's spread is accelerating, transmission is accelerating. The growing number of suspects raises the number of diagnostic tests, enhancing the country's market growth. For example, in April 2020, the US FoodU.S.nd Drug Administration approved the first COVID-19 diagnostic test with a home collection option. The FDA has reissued the emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test to allow testing of samples collected at home by patients utilizing LabCorp's Pixel by LabCorp COVID-19 Test home collection kit.
Furthermore, according to Cancer Statistics 2021, published in the American Cancer Society Journal, there are an expected 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States, which will considerably boost the Market. Introducing new products based on PCR tests will considerably b the market growth. For example, in September 2020, Roche acquired FDA approval for the cobas HIV-1/HIV-2 Qualitative Test to be used on the fully automated Cobas 6800/8800 Systems in the United States. The test will assist healthcare practitioners in verifying HIV diagnosis with a single test and distinguishing HIV-1 and HIV-2, an important distinction required to determine optimal treatment options. This test is based on PCR technology, cutting diagnosis time by one week and increasing market demand.
Global Polymerase Chain Reaction Market: Competitive Landscape
In October 2021, Thermo Fisher Scientific, based in the United States, launched the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide very accurate and consistent findings in genetic analysis and research in 90 minutes. Moreover, in March 2021, Agilent Technologies Inc. announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit to detect SARS-CoV-2 RNA. The CE-IVD mark is by the European Union In-Vitro Diagnostic Directive 98/79/EC, and E.C. is available for immediate distribution.
Few of the Polymerase Chain Reaction Market players include Thermo Fisher Scientific Inc., Danaher, Standard BioTools, Abbott, Stilla, F-Hoffman-La Roche Ltd., Bio-Rad Laboratories, Agilent Technologies, Inc., Qiagen, Microsynth AG.
Regional Classification of the Global Polymerase Chain Reaction Market is Described Below:
Middle East and Africa
*Regions and countries are subject to change based on data availability
Key Elements Included In The Study: Global Polymerase Chain Reaction Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.View Methodology